Home > Insider Trading > Filing (0001209191-23-008025)

Filing Details

Accession Number:: 0001209191-23-008025
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-02-09 16:36:02
Reporting Period:: 2023-02-03

Accepted Time:: 2023-02-09 16:36:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1831828	Vera Therapeutics Inc.	VERA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184592	C Beth Seidenberg	C/O Vera Therapeutics, Inc. 8000 Marina Boulevard, Suite 120 Brisbane CA 94005		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2023-02-03	46,163	$7.24	1,389,315	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2023-02-06	131,602	$7.03	1,520,917	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2023-02-07	87,956	$7.08	1,608,873	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2023-02-08	45,357	$7.22	1,654,230	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

The shares were purchased as follows: 44,635 by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 1,528 by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI and XVI Founders is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and XVI Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI and XVI Founders except to the extent of their pecuniary interest therein.
Represents weighted average purchase price. The shares were purchased at prices ranging from $7.21 to $7.25. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Consists of 1,343,330 shares of Class A Common Stock held by KPCB XVI and 45,985 shares of Class A Common Stock held by XVI Founders.
The shares were purchased as follows: 127,246 by KPCB XVI and 4,356 by XVI Founders.
Represents weighted average purchase price. The shares were purchased at prices ranging from $6.86 to $7.24. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Consists of 1,470,576 shares of Class A Common Stock held by KPCB XVI and 50,341 shares of Class A Common Stock held by XVI Founders.
The shares were purchased as follows: 85,045 by KPCB XVI and 2,911 by XVI Founders.
Represents weighted average purchase price. The shares were purchased at prices ranging from $6.97 to $7.25. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Consists of 1,555,621 shares of Class A Common Stock held by KPCB XVI and 53,252 shares of Class A Common Stock held by XVI Founders.
The shares were purchased as follows: 43,856 by KPCB XVI and 1,501 by XVI Founders.
Represents weighted average purchase price. The shares were purchased at prices ranging from $7.06 to $7.25. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Consists of 1,599,477 shares of Class A Common Stock held by KPCB XVI and 54,753 shares of Class A Common Stock held by XVI Founders.